A Medical Device Daily
Zoll Medical (Chelmsford, Massachusetts) and Masimo (Irvine, California) reported a multi-year technology agreement to integrate Masimo's Rainbow SET technology into Zoll E Series defibrillators.
The agreement allows Zoll to manufacture these defibrillators with this technology, which non-invasively and continuously measures carbon monoxide (SpCO) and methemoglobin (SpMet) levels in the blood.
"Masimo Rainbow SET Pulse CO-Oximetry non-invasively delivers the advanced clinical intelligence that today's EMS and fire professionals need to accurately diagnose and treat victims of carbon monoxide poisoning," said Zoll Chairman/CEO Richard Packer. "This agreement will allow us to add this important parameter in the future to help rescuers advance their lifesaving efforts."
Carbon monoxide (CO) is a dangerous silent killer that is often very difficult to diagnose. If left untreated, it can have significant morbidity and mortality consequences.
Masimo Rainbow SET has the potential to help clinicians improve patient outcomes through more rapid diagnosis of potentially life-threatening conditions — including carbon monoxide poisoning and methemoglobinemia — allowing them to make better and earlier treatment decisions.
In other agreements/contracts news:
• SciQuest (Cary, North Carolina) has formed a strategic alliance with Qiagen (Venlo, the Netherlands) to help Qiagen's customers realize the efficiencies of procurement automation through faster, easier access to crucial diagnostics and research supplies.
"We were one of the first suppliers to join the SciQuest Supplier Network in 2000. We decided to do so because we knew that procurement automation can offer a win-win situation: customers realize the efficiencies they seek and Qiagen can efficiently compete for greater market share," said Matthias Raquet, senior director, global service solutions at Qiagen. "Our commitment to enhance our ecommerce presence, of which this alliance is a part, stems from our continual commitment to make working with Qiagen as easy and effective as possible."
As part of the alliance, Qiagen will work closely with customers to explore ways they can take advantage of ecommerce capabilities to generate costs savings and process efficiencies. Through SciQuest's eprocurement solution suite, customers can realize the benefits of procurement automation to easily access and order Qiagen consumables, instruments and services online.
• SpineSmith Partners (Austin, Texas) said it is collaborating with several senior design teams in the Biomedical Engineering Department at the University of Texas (also Austin) to help educate students on the design, engineering and commercialization process of medical devices.
The groups of biomedical engineering students will work closely with SpineSmith's product engineers and PhDs to take ideas conceptualized by practicing spine surgeons and design products for commercialization. This design process will educate the students and offer real world experience in the medical device industry.
SpineSmith is researching and developing different technologies using a patient's own adult stem cells for tissue regeneration in orthopedics and the spine.
• To help meet the growing global demand for cancer treatment, the University of Pittsburgh Medical Center (UPMC) reported a collaboration with GE Healthcare (Chalfont St. Giles, England) to develop cancer centers internationally.
This effort will provide UPMC's world-renowned cancer expertise to patients now lacking such care. GE Healthcare will provide and service all the medical equipment that it is capable of supplying to these facilities.
UPMC already operates one of the largest cancer programs in the U.S., serving 30,000 newly diagnosed patients annually through more than 40 centers in western Pennsylvania. UPMC also manages two cancer centers in Ireland.
As part of this collaboration GE Healthcare will conduct assessments to determine which markets are most appropriate for cancer centers.